The Eye Care Blog

Epi-LASIK is a surface treatment procedure that provides options for patients who were previously not good candidates for LASIK.

Epi-LASIK, which features the Epikeratome System, is U.S. Food and Drug Administration (FDA) 510(k)-approved and a European CE certified instrument. With this new system, surgeons can reduce the chance of post-surgical risks and complications associated with LASIK, such as dry eye.

This technology also offers new surgical vision correction options for patients who have been non-candidates for LASIK due to dry eyes, thin corneas or high myopia.

In traditional LASIK surgery, a flap is created with the use of a blade or laser. The Epi-LASIK system utilizes a separator rather than a blade to create a thin sheet of surface cells and eliminates the need for alcohol or other chemical agents, which can be toxic to the cornea. Because of this, complications sometimes associated with the blade, such as flap complications or aberrations induced by the flap, can be eliminated. Following the application of the laser correction to the cornea, the thin sheet is returned to its original position.

Custom or wavefront-guided laser treatments are best when coupled with the Epi-LASIK surface treatment rather than the flap-based technology because of the reduced risk of flap induced aberrations.

Link

Filed under Dry Eyes, Eye Treatment, Lasik Eye Surgery, Refractive Eye Surgery

You may also like to read

• iLASIK May Be Safer Than Traditional LASIK Surgery
• LASIK Surgery: Pre-Operative Corneal Thickness Not Linked to Post-LASIK Surgery Keratectasia
• LASIK Surgery Complications; Treatable
• Hard Facts on Laser Eye Surgery (Lasik Surgery)
• InterWave Aberrometry Guided LASIK Improves Mesopic Vision (Less Halo) Over Standard LASIK
• CustomVue Monovision Lasik Got Federal Approval
• Lasik Surgery Personal Experiences - Part 1
• Complications With LASIK Surgery- A Story
• Understanding the Basics of IntraLase or IntraLasik Surgery
• Best of The Fortnight Ending 20th November 2005

This entry was posted on Monday, November 14th, 2005 at 10:58 pm. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.